NAFLD, Cardiovascular Risk and Atherosclerosis
A practical guide to the most common chronic liver disease
(Sprache: Englisch)
Non-Alcoholic Fatty Liver Disease (NAFLD) often anticipates many years the onset of metabolic syndrome-associated alterations including hypertension, type 2 diabetes and atherogenic dyslipidemia. Thus, NAFLD should be known by clinicians and general...
Leider schon ausverkauft
versandkostenfrei
Buch
35.90 €
17 DeutschlandCard Punkte
sammeln
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
Produktdetails
Produktinformationen zu „NAFLD, Cardiovascular Risk and Atherosclerosis “
Klappentext zu „NAFLD, Cardiovascular Risk and Atherosclerosis “
Non-Alcoholic Fatty Liver Disease (NAFLD) often anticipates many years the onset of metabolic syndrome-associated alterations including hypertension, type 2 diabetes and atherogenic dyslipidemia. Thus, NAFLD should be known by clinicians and general practitioners since, once diagnosed, patients should undergo extensive assessment for cardiovascular risk and receive indications about lifestyle changes for the prevention of the early onset of alterations related to cardiovascular risk. The suggested diagnostic algorithm includes the easiest and widely available investigations, to reduce health care costs and to allow an effective approach even in not particularly complex and specialized clinical contexts.
Bibliographische Angaben
- Autoren: Elisabetta L. Romeo , Angela Amante , Carmelo Caserta
- 2018, 60 Seiten, Maße: 22 cm, Kartoniert (TB), Englisch
- Verlag: LAP Lambert Academic Publishing
- ISBN-10: 6137339785
- ISBN-13: 9786137339787
Sprache:
Englisch
Kommentar zu "NAFLD, Cardiovascular Risk and Atherosclerosis"
0 Gebrauchte Artikel zu „NAFLD, Cardiovascular Risk and Atherosclerosis“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "NAFLD, Cardiovascular Risk and Atherosclerosis".
Kommentar verfassen